Axogen, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Axogen, Inc. (AXGN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-02-24
- Axogen, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2017-09-30 was 191.28K shares.
- Axogen, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2017-06-30 was 107.25K shares.
- Axogen, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2017-03-31 was 337.00K shares.
- Axogen, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2015-06-30 was 26.00K shares, a 88.60% decline year-over-year.
- Axogen, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 0.00 shares.
- Axogen, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 656.40K shares, a 1.01% decline from fiscal 2020.
- Axogen, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2020 was 663.10K shares.
- Axogen, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2012 was 267.58K shares, a 76.57% decline from fiscal 2011.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00 shares 10-K · filed 2026-02-24 | |||
| 2021-12-31 | 656.40K shares 10-K · filed 2022-02-25 | |||
| 2020-12-31 | 663.10K shares 10-K · filed 2022-02-25 | |||
| 2017-09-30 | 191.28K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | 298.52K shares derived: sum of 2 quarters · filed 2017-11-01 | 635.52K shares 10-Q · filed 2017-11-01 | |
| 2017-06-30 | 107.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | 444.25K shares 10-Q · filed 2017-08-02 | ||
| 2017-03-31 | 337.00K shares 10-Q · filed 2017-05-04 | |||
| 2015-06-30 | 26.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | 295.50K shares 10-Q · filed 2015-08-06 | ||
| 2015-03-31 | 269.50K shares 10-Q · filed 2015-05-05 | |||
| 2014-09-30 | 22.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | 250.25K shares derived: sum of 2 quarters · filed 2014-11-13 | 476.25K shares 10-Q · filed 2014-11-13 | |
| 2014-06-30 | 228.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | 454.00K shares 10-Q · filed 2014-08-04 | ||
| 2014-03-31 | 226.00K shares 10-Q · filed 2014-04-30 | |||
| 2013-09-30 | 65.50K shares 10-Q · filed 2013-10-30 | 105.50K shares derived: sum of 2 quarters · filed 2013-10-30 | 231.50K shares 10-Q · filed 2013-10-30 | 286.00K shares derived: sum of 4 quarters · filed 2013-10-30 |
| 2013-06-30 | 40.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | 193.00K shares 10-Q · filed 2013-08-14 | 220.50K shares derived: sum of 3 quarters · filed 2013-08-14 | 239.50K shares derived: sum of 4 quarters · filed 2013-08-14 |
| 2013-03-31 | 153.00K shares 10-Q · filed 2013-04-30 | 180.50K shares derived: sum of 2 quarters · filed 2013-08-07 | 199.50K shares derived: sum of 3 quarters · filed 2013-08-07 | |
| 2012-12-31 | 27.50K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-08-07 | 46.50K shares derived: sum of 2 quarters · filed 2013-08-07 | 267.58K shares 10-K/A · filed 2013-08-07 | |
| 2012-09-30 | 19.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | 240.08K shares 10-Q · filed 2012-11-06 | ||
| 2012-06-30 | 221.08K shares 10-Q · filed 2012-08-14 | |||
| 2011-12-31 | 1.14M shares 10-K/A · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |